Home / Infectious Disease & Vaccines
Infectious Disease & Vaccines
| 3 min read
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections
| 8 min read
HIV is incurable because it hides in latently infected cells. Researchers are hoping to change that — and prevent new infections — with the use of antibodies.
| 4 min read
During mold infection, a cytokine sends signals to neutrophils to kill invading fungal spores in the lungs, enhancing survival.
| 2 min read
Collaboration to leverage Oxford Nanopore’s sequencing platform and Cepheid’s GeneXpert system to advance the field of sequencing for infectious diseases.
| 8 min read
Scientists are turning to breath samples as a way to detect tuberculosis economically and conveniently.
| 3 min read
A new antifungal drug, mandimycin, tackles resistant fungal strains with a never-before-seen mechanism that avoids kidney toxicity.
| 1 min read
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
| 4 min read
Scientists probed how tick proteins influenced host immunity, paving the way for mRNA vaccines to block Lyme and other tick-borne diseases.
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
| 3 min read
Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.
| 4 min read
Innovations like ClinFAST™ are streamlining the fill/finish process, reducing timelines while maintaining high-quality standards for clinical materials.
| 8 min read
Virus-inspired delivery methods enable gene editing of dysregulated microbes.
Available on Demand
Discover how glycoscience is transforming how scientists understand diseases and opening new doors for drug discovery.
| 4 min read
A strain of E. coli linked to Crohn’s disease produces a compound that triggers intestinal scarring, revealing a potential treatment path.
| 9 min read
New phenotypic methods can help identify the best antibiotic to treat sepsis, UTIs, and other bacterial infections.
| 3 min read
In vivo studies of the antibiotic darobactin D22 against high-priority gram-negative bacteria show promise for further drug development.
| 8 min read
Bacteria from healthy vaginas show promise in protecting women from pathogens, but advancing their development requires more funding and research.
| 5 min read
A compound that inhibits replication of the dengue virus in mammals was similarly effective in mosquitoes consuming it via blood, reducing transmissibility.
| 3 min read
Sulopenem becomes the first oral penem antibiotic approved in the United States, expanding non-IV treatment options for UTIs.
| 4 min read
In some kids, an RSV infection is mild, while others are hospitalized. Natural killer cells might be the reason why.
Page 1 of 213 - 4246 Total Items
